시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 복합부위 통증 증후군(CRPS)용 디지털 치료제 시장 보고서(2025년)
Digital Therapeutics Complex Regional Pain Syndrome Global Market Report 2025
상품코드 : 1877609
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

복합부위 통증 증후군(CRPS)용 디지털 치료제 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 8억 9,000만 달러에서 2025년에는 10억 5,000만 달러에 달할 것으로 추정되며, CAGR 17.9%로 성장이 전망되고 있습니다. 이 성장은 만성 통증의 부담 및 치료 부족에 대한 인식 증가, 비 약물 치료를 지원하는 오피오이드 관리 정책, 팬데믹 하에서의 원격 의료에 의한 재활 보급, 디지털 통증 프로그램 및 원격 모니터링에 관한 지불자에 의한 파일럿 사업, 그리고 가이드 라인에 기초한 생물 심리 사회적 케어의 임상 의에 의한 채용이라고 하는 요인에 기인합니다.

복합부위 통증 증후군(CRPS)용 디지털 치료제 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 20억 1,000만 달러에 달할 것으로 예측되며, CAGR 17.6%로 성장할 전망입니다. 예측 기간 동안 성장 요인으로는 정형외과 수술 및 외상 수술 후 통증 발생률 증가, 폐 루프 방식 및 후근 신경절(DRG) 신경 조절 기술 채택 확대, 임베디드 척수 자극 요법(SCS)에 대한 유리한 상환 시스템 업데이트 자가면역질환 조사를 통한 정맥내 면역글로불린(IVIG) 및 단일클론항체(Mab) 파이프라인 활동의 촉진, 객관적 통증 바이오마커를 가능하게 하는 웨어러블 바이오센서를 포함합니다. 예측 기간 주요 동향으로는 인공지능(AI)을 활용한 통증 평가 및 맞춤형 치료, 지속적 통증 모니터링을 위한 웨어러블 바이오센서, 가상현실(VR) 및 증강현실(AR) 기반의 재활 요법, 실시간 환자 추적을 위한 클라우드 플랫폼, 통증 반응 시뮬레이션 및 치료 최적화를 위한 디지털 트윈 등을 들 수 있습니다.

스마트폰 및 인터넷 접속의 보급 확대는 향후 수년간 복합부위 통증 증후군용 디지털 치료제 시장의 성장을 가속할 것으로 예측됩니다. 스마트폰과 인터넷 연결을 통해 사용자는 언제 어디서나 커뮤니케이션하고 정보에 액세스하며 온라인 서비스를 이용할 수 있습니다. 이러한 기술의 가용성 향상은 급속한 도시화에 의해 추진되고 있으며, 인프라 수요와 경제 상황이 모바일 네트워크 및 광대역 서비스의 전개를 가속화하고 있습니다. 스마트폰과 인터넷의 보급 확대는 액세스 가능한 모바일 플랫폼을 통한 지속적인 환자 참여, 원격 모니터링, 맞춤 치료 제공을 가능하게 하고, 치료 준수율 향상, 실시간 데이터 수집, 통증 관리의 종합적인 성과 향상으로 디지털 치료를 지원합니다. 예를 들어, 2025년 5월에 미국 연방통신위원회가 보고한 바에 따르면, 2023년 6월부터 2024년 6월까지의 총 접속수는 약 2.5% 증가하여 5억 4,900만 건에 달했습니다. 모바일 연결은 전년 대비 2.5% 증가한 4억 1,600만 건, 고정 연결은 약 2.3% 증가한 1억 3,300만 건이 되었습니다. 이는 스마트폰과 인터넷 연결에 대한 액세스 확대가 시장 성장을 이끌고 있음을 보여줍니다.

헬스케어 지출 증가는 복합부위 통증 증후군(CRPS)용 디지털 치료제 시장의 성장을 가속할 것으로 예측됩니다. 헬스케어 지출에는 정부, 민간 보험 회사, 기업 및 개인이 의료 서비스, 치료, 의약품 및 관련 건강 활동에 할당하는 총 자금이 포함됩니다. 지출 증가는 장기 관리와 지속적인 치료 개입이 필요한 만성 질환의 유병률 상승으로 추진되고 있습니다. 헬스케어 증가는 기존의 대면 의료의 지속적인 비용 없이 액세스가능하고 확장 가능한 통증 관리 개입을 제공하는 디지털 치료제와 같은 비용 효율적인 솔루션에 대한 수요를 지원합니다. 예를 들어, 2025년 6월 미국 메디케어 메디케이드 서비스 센터가 보고한 바에 따르면, 2023년 국내 헬스케어는 7.5% 증가하여 4조 9,000억 달러에 달했습니다. 이는 1인당 평균 1만 4,570달러, GDP의 17.6%에 해당합니다. 메디케어 지출은 8.1% 증가하여 1조 298억 달러에 이르렀으며 총 지출의 21%를 차지했습니다. 이것은 헬스케어 지출 증가가 시장 성장을 견인하고 있음을 보여줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Digital therapeutics for complex regional pain syndrome are evidence-based software treatments delivered via apps or online platforms that guide patients through validated therapies while monitoring symptoms and adherence. Their goal is to reduce pain and hypersensitivity, restore function and daily activities, and support clinicians with remote monitoring and personalized care, helping to reduce reliance on medications and frequent clinic visits.

The primary product types of digital therapeutics for complex regional pain syndrome include software, devices, and platforms. Software refers to programs and data that enable computers or devices to perform tasks, manage information, and interact effectively with users or other systems. These solutions are distributed through various channels, including online platforms, pharmacies, direct sales, and others. They are used for applications such as pain management, rehabilitation, and patient education, with key end users including hospitals, clinics, homecare settings, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics complex regional pain syndrome market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics complex regional pain syndrome market statistics, including digital therapeutics complex regional pain syndrome industry global market size, regional shares, competitors with the digital therapeutics complex regional pain syndrome market share, digital therapeutics complex regional pain syndrome market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics complex regional pain syndrome industry. This digital therapeutics complex regional pain syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics complex regional pain syndrome market size has grown rapidly in recent years. It will grow from $0.89 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth during the historic period is attributed to increasing recognition of the burden and undertreatment of chronic pain, opioid stewardship policies supporting nonpharmacological care, normalization of telehealth-delivered rehabilitation during the pandemic, payer pilots for digital pain programs and remote monitoring, and clinician adoption of guideline-supported biopsychosocial care.

The digital therapeutics complex regional pain syndrome market size is expected to see rapid growth in the next few years. It will grow to $2.01 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth during the forecast period is attributed to the rising incidence of pain following orthopedic and trauma surgeries, increasing adoption of closed-loop and dorsal root ganglion (DRG) neuromodulation, favorable reimbursement updates for implantable spinal cord stimulation (SCS), autoimmune research driving intravenous immunoglobulin (IVIG) and monoclonal antibody (Mab) pipeline activity, and wearable biosensors enabling objective pain biomarkers. Key trends in the forecast period include artificial intelligence (AI)-driven pain assessment and personalization, wearable biosensors for continuous pain monitoring, virtual reality (VR) and augmented reality (AR)-based rehabilitation therapies, cloud-based platforms for real-time patient tracking, and digital twins for simulating pain response and optimizing treatment.

The expanding access to smartphones and internet connectivity is expected to drive the growth of the digital therapeutics for complex regional pain syndrome market in the coming years. Smartphones and internet connectivity enable users to communicate, access information, and utilize online services anytime and anywhere. The increasing availability of these technologies is driven by rapid urbanization, which creates infrastructure demands and economic conditions that accelerate the deployment of mobile networks and broadband services. Greater smartphone and internet penetration supports digital therapeutics by enabling continuous patient engagement, remote monitoring, and personalized therapy delivery through accessible mobile platforms, improving treatment adherence, real-time data collection, and overall pain management outcomes. For example, in May 2025, the US Federal Communications Commission reported that total connections rose by approximately 2.5% between June 2023 and June 2024, reaching 549 million. Mobile connections increased 2.5% year-over-year to 416 million, while fixed connections grew by about 2.3% to 133 million. This demonstrates that expanding access to smartphones and internet connectivity is driving market growth.

Rising healthcare expenditure is expected to propel the growth of the digital therapeutics for complex regional pain syndrome market. Healthcare expenditure includes the total financial resources allocated by governments, private insurers, businesses, and individuals toward medical services, treatments, medications, and related health activities. Increasing expenditure is driven by the growing prevalence of chronic diseases, which require long-term management and continuous therapeutic interventions. Higher healthcare spending supports demand for cost-effective solutions such as digital therapeutics, offering accessible and scalable pain management interventions without the recurring costs of traditional in-person care. For example, in June 2025, the US Centers for Medicare & Medicaid Services reported that national health expenditures increased by 7.5% in 2023, reaching $4.9 trillion, averaging $14,570 per person and representing 17.6% of GDP. Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of total expenditures. This indicates that rising healthcare expenditure is driving market growth.

In November 2023, US-based BehaVR Inc. merged with Fern Health to form RealizedCare, a comprehensive digital care management platform for chronic pain and mental health. The merger aims to integrate digital therapeutics with traditional support services to deliver personalized, scalable, and value-based care for chronic pain and related mental health conditions. Fern Health Inc. specializes in providing virtual, evidence-based chronic pain management solutions, and the combined platform, RealizedCare, expands access to holistic digital care.

Major players in the digital therapeutics complex regional pain syndrome market are Abbott Laboratories, Hinge Health Inc., MedBridge Inc., Luna Innovations Inc., BioWave Inc., Kaia Health Software GmbH, XRHealth Inc., Vori Health Inc., AppliedVR Inc., Theranica Bio-Electronics Ltd., PainDrainer Inc., Physitrack Ltd., WellBrain Inc., Vitrue Health Inc., Upswing Health Inc., Flowly Inc., Plethy Inc., PainChek Ltd., Oska Wellness Inc., DarioHealth Corp.

North America was the largest region in the digital therapeutics complex regional pain syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics for complex regional pain syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics for complex regional pain syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for complex regional pain syndrome market consists of revenues earned by entities by providing services such as prescription digital therapeutic program delivery, virtual reality pain rehabilitation sessions, remote patient monitoring and analytics, tele coaching and behavioral therapy support, and clinician decision-support and care-plan personalization. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for complex regional pain syndrome market also includes sales of wearable sensors, monitoring devices, neurostimulation systems, and dorsal root ganglion stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Complex Regional Pain Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics complex regional pain syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for digital therapeutics complex regional pain syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics complex regional pain syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Digital Therapeutics Complex Regional Pain Syndrome Market Characteristics

3. Digital Therapeutics Complex Regional Pain Syndrome Market Trends And Strategies

4. Digital Therapeutics Complex Regional Pain Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Digital Therapeutics Complex Regional Pain Syndrome Growth Analysis And Strategic Analysis Framework

6. Digital Therapeutics Complex Regional Pain Syndrome Market Segmentation

7. Digital Therapeutics Complex Regional Pain Syndrome Market Regional And Country Analysis

8. Asia-Pacific Digital Therapeutics Complex Regional Pain Syndrome Market

9. China Digital Therapeutics Complex Regional Pain Syndrome Market

10. India Digital Therapeutics Complex Regional Pain Syndrome Market

11. Japan Digital Therapeutics Complex Regional Pain Syndrome Market

12. Australia Digital Therapeutics Complex Regional Pain Syndrome Market

13. Indonesia Digital Therapeutics Complex Regional Pain Syndrome Market

14. South Korea Digital Therapeutics Complex Regional Pain Syndrome Market

15. Western Europe Digital Therapeutics Complex Regional Pain Syndrome Market

16. UK Digital Therapeutics Complex Regional Pain Syndrome Market

17. Germany Digital Therapeutics Complex Regional Pain Syndrome Market

18. France Digital Therapeutics Complex Regional Pain Syndrome Market

19. Italy Digital Therapeutics Complex Regional Pain Syndrome Market

20. Spain Digital Therapeutics Complex Regional Pain Syndrome Market

21. Eastern Europe Digital Therapeutics Complex Regional Pain Syndrome Market

22. Russia Digital Therapeutics Complex Regional Pain Syndrome Market

23. North America Digital Therapeutics Complex Regional Pain Syndrome Market

24. USA Digital Therapeutics Complex Regional Pain Syndrome Market

25. Canada Digital Therapeutics Complex Regional Pain Syndrome Market

26. South America Digital Therapeutics Complex Regional Pain Syndrome Market

27. Brazil Digital Therapeutics Complex Regional Pain Syndrome Market

28. Middle East Digital Therapeutics Complex Regional Pain Syndrome Market

29. Africa Digital Therapeutics Complex Regional Pain Syndrome Market

30. Digital Therapeutics Complex Regional Pain Syndrome Market Competitive Landscape And Company Profiles

31. Digital Therapeutics Complex Regional Pain Syndrome Market Other Major And Innovative Companies

32. Global Digital Therapeutics Complex Regional Pain Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Complex Regional Pain Syndrome Market

34. Recent Developments In The Digital Therapeutics Complex Regional Pain Syndrome Market

35. Digital Therapeutics Complex Regional Pain Syndrome Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기